Gastric residence systems for sustained release of therapeutic agents and methods of use… Grant US-11576859-B2 United States of America 14 Feb 2023
Gastric residence systems for sustained delivery of adamantane-class drugs Grant US-11576866-B2 United States of America 14 Feb 2023
Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders Grant US-11344510-B2 United States of America 31 May 2022
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant US-10980758-B2 United States of America 20 Apr 2021
Compositions for treating amyotrophic lateral sclerosis Grant US-10682342-B2 United States of America 16 Jun 2020
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant US-10632091-B2 United States of America 28 Apr 2020
Dosage forms and therapeutic uses of L-4-chlorokynurenine Grant US-10617663-B2 United States of America 14 Apr 2020
STEP-derived peptide for brain injury treatment Grant US-10570381-B2 United States of America 25 Feb 2020
Compositions for treating amyotrophic lateral sclerosis Grant US-10342784-B2 United States of America 09 Jul 2019
Therapeutic approaches for treating Parkinson's disease Grant US-10342768-B2 United States of America 09 Jul 2019
IDALOPIRDINE-BASED COMBINATORIAL THERAPIES OF ALZHEIMER'S DISEASE Application WO-2018197383-A1 World Intellectual Property Organisation (WIPO) 01 Nov 2018
STEP-derived peptide for brain injury treatment Grant US-10087429-B2 United States of America 02 Oct 2018
Compositions for treating amyotrophic lateral sclerosis Grant US-10045971-B2 United States of America 14 Aug 2018
Therapeutic approaches for treating Parkinson's disease Grant US-10010515-B2 United States of America 03 Jul 2018
Dosage forms and therapeutic uses L-4-chlorokynurenine Grant US-9993453-B2 United States of America 12 Jun 2018
Baclofen and acamprosate based therapy of neurological disorders Grant US-9636316-B2 United States of America 02 May 2017
Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and… Grant US-9597297-B2 United States of America 21 Mar 2017
COMBINATION OF BACLOFEN, ACAMPROSATE AND MEDIUM CHAIN TRIGLYCERIDES FOR THE TREATMENT OF… Application KR-20160111013-A Republic of Korea 23 Sep 2016
APOAEQUORIN-CONTAINING COMPOSITIONS AND METHODS OF USING SAME TO TREAT NEURONAL… Application WO-2016077437-A1 World Intellectual Property Organisation (WIPO) 19 May 2016
NMDA RECEPTOR ANTAGONISTS FOR TREATING GAUCHER DISEASE Application WO-2016038616-A1 World Intellectual Property Organisation (WIPO) 17 Mar 2016
Therapeutic approaches for treating parkinson's disease Grant US-9248111-B2 United States of America 02 Feb 2016
Compositions for treating amyotrophic lateral sclerosis Grant US-9241933-B2 United States of America 26 Jan 2016
Baclofen and acamprosate based therapy of neurological disorders Grant US-9144558-B2 United States of America 29 Sep 2015
STEP-derived peptide for brain injury treatment Application US-9068172-B2 United States of America 30 Jun 2015
Baclofen and acamprosate based therapy of neurological disorders Application US-8741886-B2 United States of America 03 Jun 2014
Treatment of ocular disease with inhibitors of alpha2 macroglobulin protein Grant US-8563520-B2 United States of America 22 Oct 2013
N-methyl-D-aspartate (NMDA) receptor antagonists, such as 3-{2-[8,9-dioxo-2,6-diazabicyclo… Grant US-7879825-B2 United States of America 01 Feb 2011
Method of amidated peptide biosynthesis and delivery in vivo: endomorphin-2 for pain… Grant US-7825231-B2 United States of America 02 Nov 2010
Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic… Application EP-1982970-A1 European Patent Office 22 Oct 2008
Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic… Grant US-7253153-B2 United States of America 07 Aug 2007